Literature DB >> 25570699

Brain activation inhomogeneity highlighted by the Isotropic Anomalous Diffusion filter.

Antonio Carlos da S Senra Filho, Carlo Rondinoni, Antonio Carlos dos Santos, Luiz O Murta.   

Abstract

The visual appealing nature of the now popular BOLD fMRI may give the false impression of extreme simplicity, as if the the functional maps could be generated with the press of a single button. However, one can only get plausible maps after long and cautious processing, considering that time and noise come into play during acquisition. One of the most popular ways to account for noise and individual variability in fMRI is the use of a Gaussian spatial filter. Although very robust, this filter may introduce excessive blurring, given the strong dependence of results on the central voxel value. Here, we propose the use of the Isotropic Anomalous Diffusion (IAD) approach, aiming to reduce excessive homogeneity while retaining the natural variability of signal across brain space. We found differences between Gaussian and IAD filters in two parameters gathered from Independent Component maps (ICA), identified on brain areas responsible for auditory processing during rest. Analysis of data gathered from 7 control subjects shows that the IAD filter rendered more localized active areas and higher contrast-to-noise ratios, when compared to equivalent Gaussian filtered data (Student t-test, p<0.05). The results seem promising, since the anomalous filter performs satisfactorily in filtering noise with less distortion of individual localized brain responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25570699     DOI: 10.1109/EMBC.2014.6944331

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  1 in total

1.  A hybrid approach based on logistic classification and iterative contrast enhancement algorithm for hyperintense multiple sclerosis lesion segmentation.

Authors:  Antonio Carlos da Silva Senra Filho
Journal:  Med Biol Eng Comput       Date:  2017-11-18       Impact factor: 2.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.